Target intelligence / Profile preview

Nuclear pore complex protein Nup160 (NUP160)

Target
NUP160
Molecular classification
Nuclear pore complex component, structural protein, nucleoporin
01

Overview

Nuclear pore complex protein Nup160 (NUP160) is a structural component of the nuclear pore complex (NPC), specifically part of the Nup107–Nup160 subcomplex, which forms part of the outer ring scaffold of the NPC[1][2]. The NPC mediates macromolecular trafficking between the nucleus and cytoplasm of eukaryotic cells. Nup160 plays essential roles in nuclear–cytoplasmic transport (particularly mRNA export), mitotic spindle formation, chromosome segregation, and maintaining genome integrity[2]. Mutations in NUP160 are implicated in nephrotic syndrome type 19, including hereditary steroid-resistant forms[1][4]. Loss of Nup160 disrupts nuclear pore structure and function and leads to aberrant nuclear architecture and cellular defects[4]. NUP160 is essential for cellular and organismal viability, and its dysfunction can result in severe developmental or physiological abnormalities. There are currently no known clinically approved drugs targeting NUP160.

Other names
Nucleoporin 160KIAA0197NUP120FLJ22583160 kDa nucleoporinNucleoporin Nup160NPHS19nucleoporin 160kDnucleoporin 160kDa
02

Biological functions

Structural constituent of nuclear poremRNA export from nucleusnucleocytoplasmic transportchromosome segregationgenome integrity maintenanceregulation of gene expressioncell cycle progressiongenome organization
03

Disease associations

Nephrotic syndrome (including steroid-resistant nephrotic syndrome)genome integrity disorderspotentially cancer (through genome integrity)other
04

Safety considerations

Disruption of NUP160 is associated with nephrotic syndrome and defects in genome stabilitylikely essential for viability, so targeting poses high risk of toxicity/disruption of nuclear transport and cell division

Beyond the preview

Go deeper on Nuclear pore complex protein Nup160 (NUP160).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nuclear pore complex protein Nup160 (NUP160).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call